Wednesday December 11, 2019
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Asia 2020
    • |BioProcess International US West
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Wednesday, September 1, 2004 Daily Archives

BPI Reports

by BPI Contributor
Add Comment
September 1, 2004

What Is Test Method Qualification?

by BPI Contributor
Add Comment
September 1, 2004

Toxicity Testing

by BPI Contributor
Add Comment
September 1, 2004

Real-Time Off-Gas Analysis Improves Bioreactor Efficiency

by BPI Contributor
Add Comment
September 1, 2004

Products, Services, and Literature

by BPI Contributor
Add Comment
September 1, 2004

Navigating FDA Regulations for Human Cells and Tissues

by BPI Contributor
Add Comment
September 1, 2004

Global Meetingplace

by BPI Contributor
Add Comment
September 1, 2004

Feasibility of International Technology Transfer for the Production of Recombinant Human Insulin

by BPI Contributor
Add Comment
September 1, 2004

European Comparability Guidances Acknowledge Follow-On Manufacturers

by BPI Contributor
Add Comment
September 1, 2004

DSA-FACE

by BPI Contributor
Add Comment
September 1, 2004
  • 1
  • 2
  • >

Editor’s Choice

  • BioProcess Insider

    Astellas: Large-scale gene therapy plant major driver in $3bn Audentes deal

  • BioProcess Insider

    Lack of UK cell and gene therapy skills a concern according to CGTC survey

  • Sponsored Content

    The Road to Commercialization: A Commercial CDMO’s Perspective

  • BioProcess Insider

    China: Stainless-steel will shine as market moves to commercial

  • BioProcess Insider

    Indie 400: Eli Lilly cites tax reform in latest biomanufacturing expansion

  • Sponsored Content

    Matrix: The Highly Automated Multibioreactor Solution That Fits to Your Bench Space, Bioprocessing Needs, and Budget

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: @Amazon says Novartis’ personalized medicines operations will benefit from AI and machine learning collaboration. https://t.co/ckQrFpJ4aX 5 hours ago
  • Tweet Avatar RT @Dan5tanton: A year after ending an exclusive collaboration with #CDMO Lonza for cell culture media and buffers, Sartorius has r… https://t.co/0BfpA48eTg 1 day ago
  • Tweet Avatar The US FDA has cited manufacturing concerns in a complete response letter (CRL) rejecting Enzyvant’s regenerative t… https://t.co/2x9eEGZg0P 4 days ago
  • Tweet Avatar RT @PBOAssoc: Differences Put Aside As ICH Finalizes Guide On Post Approval Changes :: Pink Sheet https://t.co/62KaQtmBV6 1 week ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    MilliporeSigma: Over 90% growth comes from mAbs, despite new modality momentum

  • BioProcess Insider

    Fujifilm pumps $120m into US gene therapy development and manufacturing

  • BioProcess Insider

    Who got the Funk? Not Lonza, as CEO unexpectedly quits

  • BioProcess Insider

    Abuse in cell banking services a global problem, says industry consortium

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2019 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International Asia 2020
    • BioProcess International US West
  • BioProcess International Academy
  • Events